Signalling pathways in alcohol-induced liver inflammation

Journal of Hepatology

Volumn 50, Issue 6, 2009, Pages 1258-1266

  Mandrekar, Pranoti ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Kupffer cells; Macrophages; MAP kinases; TLRs; Transcription factors

Indexed keywords

ALCOHOL; CD14 ANTIGEN; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER PARENCHYMA; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; ETHANOL; HEPATITIS, ALCOHOLIC; HUMANS; KILLER CELLS, NATURAL; KUPFFER CELLS; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS;

EID: 67349255858     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.03.007     Document Type: Review

References (93)

1. Hines I.N., and Wheeler M.D. Recent advances in alcoholic liver disease III. Role of innate immune responses in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 287 (2004) G310-G314
2. Fujimoto M., Uemura M., Nakatani Y., Tsujita S., Hoppo K., Tamagawa T., et al. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 24 (2000) 48S-54S
3. McClain C.J., and Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9 (1989) 349-351
4. Khoruts A., Stahnke L., McClain C.J., Logan G., and Allen J. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13 (1991) 267-276
5. Thakur V., McMullen M.R., Ptritchard M.T., and Nagy L.E. Regulation of macrophage activation in alcoholic liver disease. J Gastroenterol Hepatol 22 (2007) S53-S56
6. Jeong W.I., Park O., and Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134 (2008) 248-258
7. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1-14
8. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
9. Saitoh S., Akashi S., Yamada T., Tanimura N., Kobayashi M., Konno K., et al. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int Immunol 16 (2004) 961-969
10. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., and Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274 (1999) 10682-10692
11. Visintin A., Mazzoni A., Spitzer J.A., and Segal D.M. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci USA 98 (2001) 12156-12161
12. Tobias P.S., Soldau K., and Ulevitch R.J. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 164 (1986) 777-793
13. Wright S.D., Tobias P.S., Ulevitch R.J., and Ramos R.A. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 170 (1989) 1231-1241
14. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
15. Dunne A., and O'Neill L.A. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett 579 (2005) 3330-3335
16. Jang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., et al. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6 (2005) 565-570
17. Simazu R., Akashi S., Ogata H., Nagai Y., Fukodome K., Miyake K., et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189 (1999) 1777-1782
18. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3 (2002) 667-672
19. Giovanni T.L., Teghanemt A., Zhang D., Coussens N.P., Dockstader W., Ramaswamy S., et al. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation of picomolar concentrations. Proc Natl Acad Sci USA 101 (2004) 4186-4191
20. Mitsuzawa H., Nishitani C., Hyakushima N., Shimzu T., Sano H., Matsushima N., et al. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice. J Immunol 177 (2006) 8133-8139
21. Szabo G., Dolganiuc A., and Mandrekar P. Pattern recognition receptors. Hepatology 44 (2006) 287-298
22. Seki E., and Brenner D.A. TLRs and adaptor molecules in liver disease: update. Hepatology 48 (2008) 322-335
23. Enomoto N., Ikejima K., Bradford B., Rivera C., Kono H., Brenner D.A., et al. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 115 (1998) 443-451
24. Uesugi T., Froh M., Arteel G.E., Bradford B.U., and Thurman R.G. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34 (2001) 101-108
25. Uesugi T., Froh M., Arteel G.E., Bradford B.U., Wheller M.D., Gabele E., et al. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol 168 (2002) 2963-2969
26. Yin M., Bradford B.U., Wheeler M.D., Uesugi T., Froh M., Goyert S.M., et al. Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 166 (2001) 4742-4747
27. Romics Jr. L., Mandrekar P., Kodys K., Velayudham A., Drechsler Y., Dolganiuc A., et al. Increased lipopolysaccharide sensitivity in alcoholic fatty livers is independent of leptin deficiency and Toll-like receptor 4 (TLR4) or TLR2 mRNA expression. Alcohol Clin Exp Res 29 (2005) 1018-1026
28. Paik Y.H., Schwabe R.F., Bataller R., Russo M.P., Jobin C., and Brenner D.A. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37 (2003) 1043-1055
29. Deaciuc I.V., and Spitzer J.J. Hepatic sinusoidal endothelial cell in alcoholemia and endotoxemia. Alcohol Clin Exp Res 20 (1996) 607-614
30. Nagy L.E. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med 228 (2003) 882-890
31. Gustot T., Lemmers A., Moreno C., Nagy N., Quertinmont E., Nicaise C., et al. Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43 (2006) 989-1000
32. Hritz I., Mandrekar P., Velayudham A., Catalano D., Dolganiuc A., Kurt-Jones E., et al. The critical role of Toll-like receptor 4 in alcoholic liver disease is independent of the common TLR adaptor, MyD88. Hepatology 48 (2008) 1224-1231
33. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., et al. LPS-TLR4 signaling to IRF-3 3/7 and NF-kappaB involves the Toll adaptors TRAM and TRIF. J Exp Med 198 (2003) 1043-1055
34. Kawai T., Takeuchi O., Fujita T., Inoue J., Mühlradt P.F., Sato S., et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167 (2001) 5887-5894
35. Takeda K., and Akira S. TLR signaling pathways. Semin Immunol 16 (2004) 3-9
36. Yamamoto M., Sata S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301 (2003) 640-643
37. Yamashina S., Wheeler M.D., Rusyn I., Ikejima K., Sato N., and Thurman R.G. Tolerance and sensitization to endotoxin in Kupffer cells caused by acute ethanol involve interleukin-1 receptor-associated kinase. Biochem Biophys Res Commun 277 (2000) 686-690
38. Oak S., Mandrekar P., Catalano D., Kodys K., and Szabo G. TLR2- and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes. J Immunol 176 (2006) 7628-7635
39. Pruett S.B., Zheng Q., Fan R., Matthews K., and Schwab C. Acute exposure to ethanol affects Toll-like receptor signaling and subsequent responses: an overview of recent studies. Alcohol 33 (2004) 235-239
40. Zhao X.J., Dong Q., Bindas J., Piganelli J.D., Magill A., Reiser J., et al. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 181 (2008) 3049-3056
41. Mandrekar P., Dolganiuc A., Bellerose G., Kodys K., Romics L., Nizamani R., et al. Acute alcohol inhibits the induction of nuclear regulatory factor kappa B activation through CD14/Toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory kappa B alpha degradation?. Alcohol Clin Exp Res 26 (2002) 1609-1614
42. Mandrekar P., Catalano D., White B., and Szabo G. Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10. Alcohol Clin Exp Res 30 (2006) 135-139
43. Kono H., Rusyn I., Yin M., Gäbele E., Yamashina S., Dikalova A., et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 106 (2000) 867-872
44. Thakur V., McMullen M.R., Wang Q., and Nagy L.E. Enhanced LPS-stimulated ERK 1/2 activation and TNF alpha secretion by rat Kupffer cells after chronic ethanol feeding is mediated via increased production of reactive oxygen species (ROS) by NADPH oxidase. Hepatology 42 (2005) 571A
45. Park H.S., Jung H.Y., Park E.Y., Kim J., Lee W.J., and Bae Y.S. Cutting edge: direct interaction of TLR4 with NADPH oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 173 (2004) 3589-3593
46. Dasu M.R., Devaraj S., Ling Z., Hwang D.H., and Jialal I. High glucose induces Toll-like receptor expression in human monocytes: mechanisms of activation. Diabetes 57 (2008) 3090-3098
47. Cao Q., Mak K.M., and Leiber C.S. Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB. Biochem Biophys Res Comm 294 (2002) 849-853
48. Ghosh S. Regulation of inducible gene expression by the transcription factor NF-kappaB. Immunol Res 19 (1999) 183-189
49. Wheeler M.D., Yamashina S., Froh M., Rusyn I., and Thurman R.G. Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production. J Leukoc Biol 69 (2001) 622-630
50. Nanji A.A., Jokelainen K., Rahemtulla A., Miao L., Fogt F., Matsumoto H., et al. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30 (1999) 934-943
51. Hill D.B., Barve S., Joshi-Barve S., and McClain C. Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis. J Lab Clin Med 135 (2000) 387-395
52. Mandrekar P., Catalano D., and Szabo G. Inhibition of lipopolysaccharide-mediated NFkappaB activation by ethanol in human monocytes. Int Immunol 11 (1999) 1781-1790
53. Mandrekar P., Catalano D., and Szabo G. Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. Alcohol Clin Exp Res 21 (1997) 988-994
54. Angel P., and Karin M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochem Biophys Acta 1072 (1991) 129-157
55. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 (2001) 2390-2400
56. Wheeler M.D., and Thurman R.G. Upregulation of CD14 in liver due to acute ethanol involves oxidant-dependent AP-1 pathway. J Biol Chem 278 (2003) 8345-8351
57. Norkina O., Dolganiuc A., Shapiro T., Kodys K., Mandrekar P., and Szabo G. Acute alcohol activates STAT3, AP-1, and Sp-1 transcription factors via the family of Src kinases to promote IL-10 production in human monocytes. J Leukoc Biol 82 (2007) 752-762
58. Casini A., Galli G., Salzano R., Ceni E., Franceschelli F., Rotella C.M., et al. Acetaldehyde induces c-Fos and c-Jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation. Alcohol Alcohol 29 (1994) 303-314
59. Kishore R., Hill J.R., McMullen M.R., Frenkel J., and Nagy L.E. ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 282 (2002) G6-G15
60. Gashler A., and Sukhatme V.P. Early growth response protein 1 (Egr-1) prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 50 (1995) 191-224
61. Yan S.F., Fujita T., Lu J., Okada K., Zou Y.S., Mackman N., et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 6 (2000) 1355-1361
62. Pritchard M.T., and Nagy L.E. Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res 29 (2005) 146S-150S
63. McMullen M.R., Pritchard M.T., Wang Q., Millward C.A., Croniger C.M., and Nagy L.E. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 128 (2005) 2066-2076
64. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
65. Kisseleva T., Bhattacharya S., Braunstein J., and Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285 (2002) 1-24
66. Kerr I.M., Costa-Pereira A.P., Lillemeier B.F., and Strobl B. Of JAKs, STATs, blind watchmakers, jeeps and trains. FEBS Lett 3 (2003) 1-5
67. Norkina O., Dolganiuc A., Catalano D., Kodys K., Mandrekar P., Syed A., et al. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes. Alcohol Clin Exp Res 32 (2008) 1565-1573
68. Chen J., Clemens D.L., Cederbaum A.I., and Gao B. Ethanol inhibits the JAK-STAT signaling pathway in fresh isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism. Clin Biochem 34 (2001) 203-209
69. Horiguchi N., Ishac E.J., and Gao B. Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation. Alcohol 41 (2007) 271-280
70. Horiguchi N., Wang L., Mukhopadhyay P., Park O., Jeong W.I., Lafdil F., et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134 (2008) 1148-1158
71. Yao J., Mackman N., Edgington T.S., and Fan S.T. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells: regulation by Egr-1, c-jun and NF-kappaB transcription factors. J Biol Chem 272 (1997) 17795-17801
72. Shi L., Kishore R., McMullen M.R., Frenkel J., and Nagy L.E. Chronic ethanol increases lipopolysaccharide stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor alpha production. J Biol Chem 277 (2002) 14777-14785
73. Kishore R., McMullen M.R., and Nagy L.E. Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathways. J Biol Chem 276 (2001) 41930-41937
74. Mahtani K.R., Brook M., Dean J.L., Sully G., Saklatvala J., and Clark A.R. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21 (2001) 6461-6469
75. Drechsler Y., Dolganiuc A., Norkina O., Romics L., Li W., Kodys K., et al. Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes. J Immunol 177 (2006) 2592-2600
76. Goral J., and Kovacs E.J. In vivo ethanol exposure down-regulations TLR2-, TLR4-, and TLR9-mediated macrophage inflammatory response by limiting p38 and ERK1/2 activation. J Immunol 174 (2005) 456-463
77. Song Z., Zhou Z., Uriarte S., Wang S., Kang Y.J., Chen T., et al. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease. Hepatology 40 (2004) 989-997
78. McClain C., Hill D., Schmidt J., and Diehl A.M. Cytokines and alcoholic liver disease. Semin Liver Dis 13 (1993) 170-182
79. Honchel R., Ray M., Marsano L., Cohen D., Lee E., Shedlofsky S., et al. Tumor necrosis factor in alcohol-enhanced endotoxin liver injury. Alcohol Clin Exp Res 16 (1992) 665-669
80. Thurman R.G. Mechanisms of hepatic toxicity. III. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275 (1998) G605-G611
81. Tilg H., Jalan R., Kaser A., Davies N.A., Offner F.A., Hodges S.I., et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 38 (2003) 419-425
82. Imuro Y., Gallucci R.M., Luster M.I., Kono H., and Thurman R.G. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26 (1997) 1530-1537
83. Yin M., Wheeler M.D., Kono H., Bradford B.U., Gallucci R.M., Luster M.I., et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117 (1999) 942-952
84. McClain C.J., Barve S., Barve S., Deaciuc I., and Hill D.B. Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res 22 (1998) 248S-252S
85. Olleros M.L., Martin M.L., Vesin D., Fotio A.L., Santiago-Rober M.L., Rubbia-Brandt L., et al. Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines. Cytokine 44 (2008) 118-125
86. Schmidt-Weber C.B., and Blaser K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 16 (2004) 709-716
87. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy - review of a new approach. Pharmacol Rev 55 (2003) 241-269
88. Liew F.Y., Xu D., Brint E.K., and Oneill L.A. Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol 5 (2005) 446-458
89. Hill D.B., D'Souza N.B., Lee E.Y., Burikhanov R., Deaciuc I.V., and deVilliers W.J. A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26 (2002) 74-82
90. Thakur V., Prtichard M.T., McMullen M.R., and Nagy L.E. Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 290 (2006) G998-G1007
91. Huang H., Park P.H., McMullen M.R., and Nagy L.E. Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J Gastroenterol Hepatol 23 (2008) S850-S853
92. Mandrekar P., Catalano D., Girouard L., and Szabo G. Human monocyte IL-10 production is increased by acute ethanol treatment. Cytokine 8 (1996) 567-577
93. Szabo G., Mandrekar P., Girouard L., and Catalano D. Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production. Alcohol Clin Exp Res 20 (1996) 900-907